Where I see patients (2)
Flashback Foreword: Erlotinib and Gemcitabine in Pancreatic Cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Interindividual variation in human cortical cell type abundance and expression.
Science (New York, N.Y.)
Maintenance Treatment for Metastatic Pancreatic Cancer: Balancing Therapeutic Intensity with Tolerable Toxicity.
Testing the Use of the Usual Chemotherapy Before and After Surgery for Removable Pancreatic Can...
Overall survival is defined as the time from randomization to death due to any cause. The median and 95% confidence intervals are estimated using the Kaplan-Meier estimator. The treatment arms will be compared using a stratified C...
A Study of Ivaltinostat Plus Capecitabine or Capecitabine in Metastatic Pancreatic Adenocarcino...
The percentage of subjects who experience a grade 3 or higher adverse event that qualifies as a DLT
Trial of Ulixertinib in Combination With Hydroxychloroquine in Patients With Advanced Gastroint...
To assess the efficacy of ulixertinib and hydroxychloroquine in patients with advanced, RAS, non-V600 BRAF, ERK, or MEK mutated gastrointestinal malignancies